Medtronic Cardiovascular — Net Sales increased by 0.6% to $3.46B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 13.8%, from $3.04B to $3.46B. Over 4 years (FY 2021 to FY 2025), Cardiovascular — Net Sales shows an upward trend with a 4.1% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Higher sales indicate strong market adoption, successful product launches, or effective sales execution.
This represents the total revenue generated from the sale of cardiovascular products, net of returns, discounts, and all...
Comparable to net revenue reported for cardiovascular business units at major medical device peers.
mdt_segment_cardiovascular_net_sales| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $3.01B | $2.89B | $2.83B | $2.75B | $2.74B | $2.71B | $2.77B | $2.77B | $3.00B | $2.85B | $2.92B | $2.93B | $3.18B | $3.01B | $3.10B | $3.04B | $3.68B | $3.29B | $3.44B | $3.46B |
| QoQ Change | — | -4.0% | -2.2% | -2.9% | -0.1% | -1.0% | +2.2% | -0.0% | +8.3% | -5.0% | +2.6% | +0.2% | +8.5% | -5.4% | +3.2% | -2.1% | +21.3% | -10.8% | +4.6% | +0.6% |
| YoY Change | — | — | — | — | -8.9% | -6.1% | -1.9% | +1.0% | +9.5% | +5.0% | +5.4% | +5.7% | +5.9% | +5.5% | +6.1% | +3.7% | +15.9% | +9.2% | +10.8% | +13.8% |